reSee.it Video Transcript AI Summary
The transcript discusses self-amplifying replicon mRNA injections and asserts that they are being deployed for both humans and animals globally. It states that the UK approved Arcturus Therapeutics’ self-amplifying COVID-19 vaccine for adults over 18, and that the European Union previously approved the same inoculation for adults, placing it in both the EU and the UK. It also claims that Japan approved it in 2023, and that India has approved these replicon injections as well, indicating a global rollout. It highlights that in the United States, the USDA approved the self-amplifying mRNA particle injections for pets, specifically mentioning Merck’s Novavax NXT for dogs and cats, and asserts that this is being injected into pets and that shedding onto human owners across the US is possible. It notes that the FDA has fast-tracked an H5N1 bird flu replicon injection trial, emphasizing concern about these developments.
The speaker outlines purported dangers of these replicating genetic materials, including the possibility of shedding from humans to humans or from pets to humans, and the potential for recombination with wild viruses to create chimeric mutants. It emphasizes the claimed approval of Arcturus Therapeutics’ injection “everywhere in the clinical trials” and then provides adverse event statistics: eighty-five percent suffered systemic adverse events, and fifteen percent required medical attention. A Uganda study is cited, claiming that the replicon injections induced severe blood abnormalities in ninety-three percent of recipients, with thrombocytopenia, lymphopenia, and neutropenia reported, implying degraded immune systems and increased risks of internal bleeding in a majority of participants. The Uganda study is also described as showing eighty-five percent experiencing vomiting, high fevers, and feeling absolutely terrible.
The speaker concludes with a strong stance against these injections, calling them a “self amplifying assault on humanity” and arguing that they should be pulled off the market and banned for human use. The overall message is a warning about global deployment, potential shedding and recombination risks, significant adverse event rates, and a call to ban self-amplifying mRNA injections for humans. The named entities include Arcturus Therapeutics, Merck, Novavax NXT, and references to regulatory actions in the UK, EU, Japan, India, and the US.